HRT Financial’s Enliven Therapeutics ELVN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2022
Q4
Sell
-3,948
Closed -$36K 2434
2022
Q3
$36K Buy
+3,948
New +$36K ﹤0.01% 2270
2021
Q4
Sell
-5,800
Closed -$94K 3078
2021
Q3
$94K Buy
5,800
+321
+6% +$5.2K ﹤0.01% 2652
2021
Q2
$173K Buy
+5,479
New +$173K ﹤0.01% 2344